Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darius Häusler

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|January 11, 2019
Vitamin D Supplementation in Central Nervous System Demyelinating Disease-Enough Is EnoughDarius Häusler, Martin S Weber
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Towards Treating Multiple Sclerosis ProgressionDarius Häusler, Martin S Weber
Frontiers in Immunology|March 13, 2020
High-Dose Vitamin D-Mediated Hypercalcemia as a Potential Risk Factor in Central Nervous System Demyelinating DiseaseDarius Häusler, Sebastian Torke, Martin S Weber
International Journal of Molecular Sciences|April 3, 2021
Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression?Anastasia Geladaris, Darius Häusler, Martin S Weber
Neurology(R) Neuroimmunology & Neuroinflammation|April 18, 2023
Natalizumab Promotes Activation of Peripheral Monocytes in Patients With Multiple SclerosisEsther S Frisch, Darius Häusler, Martin S Weber
Neuropathology and Applied Neurobiology|February 3, 2015
Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis modelDarius Häusler, Stefan Nessler, Niels Kruse, et al.
Frontiers in Immunology|March 25, 2026
Glatiramer acetate stimulates phagocytosis and intracellular killing of <i>Escherichia coli</i> by macrophages and microglial cellsJana Seele, Darius Häusler, Roxana Heidemann, et al.
Annals of Neurology|September 13, 2021
Proinflammatory CD20<sup>+</sup> T Cells are Differentially Affected by Multiple Sclerosis TherapeuticsCorinna Quendt, Jasmin Ochs, Silke Häusser-Kinzel, et al.
Acta Neuropathologica Communications|December 2, 2025
Siponimod inhibits disease-associated microglia-T cell interactions in chronic experimental autoimmune encephalomyelitisLeila Husseini, Anastasia Geladaris, Marlene C J Steinleitner, et al.
Brain Pathology (Zurich, Switzerland)|May 6, 2021
CNS inflammation after natalizumab therapy for multiple sclerosis: A retrospective histopathological and CSF cohort studyDarius Häusler, Katja Akgün, Lidia Stork, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|January 11, 2019
Vitamin D Supplementation in Central Nervous System Demyelinating Disease-Enough Is EnoughDarius Häusler, Martin S Weber
Pharmaceuticals (Basel, Switzerland)|November 27, 2024
Towards Treating Multiple Sclerosis ProgressionDarius Häusler, Martin S Weber
Frontiers in Immunology|March 13, 2020
High-Dose Vitamin D-Mediated Hypercalcemia as a Potential Risk Factor in Central Nervous System Demyelinating DiseaseDarius Häusler, Sebastian Torke, Martin S Weber
International Journal of Molecular Sciences|April 3, 2021
Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression?Anastasia Geladaris, Darius Häusler, Martin S Weber
Neurology(R) Neuroimmunology & Neuroinflammation|April 18, 2023
Natalizumab Promotes Activation of Peripheral Monocytes in Patients With Multiple SclerosisEsther S Frisch, Darius Häusler, Martin S Weber
Neuropathology and Applied Neurobiology|February 3, 2015
Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis modelDarius Häusler, Stefan Nessler, Niels Kruse, et al.
Frontiers in Immunology|March 25, 2026
Glatiramer acetate stimulates phagocytosis and intracellular killing of <i>Escherichia coli</i> by macrophages and microglial cellsJana Seele, Darius Häusler, Roxana Heidemann, et al.
Annals of Neurology|September 13, 2021
Proinflammatory CD20<sup>+</sup> T Cells are Differentially Affected by Multiple Sclerosis TherapeuticsCorinna Quendt, Jasmin Ochs, Silke Häusser-Kinzel, et al.
Acta Neuropathologica Communications|December 2, 2025
Siponimod inhibits disease-associated microglia-T cell interactions in chronic experimental autoimmune encephalomyelitisLeila Husseini, Anastasia Geladaris, Marlene C J Steinleitner, et al.
Brain Pathology (Zurich, Switzerland)|May 6, 2021
CNS inflammation after natalizumab therapy for multiple sclerosis: A retrospective histopathological and CSF cohort studyDarius Häusler, Katja Akgün, Lidia Stork, et al.
Pageof 3